There Is Clear Momentum For Repligen Corp (NASDAQ: RGEN)
Repligen Corp (RGEN) concluded trading on Wednesday at a closing price of $154.70, with 0.44 million shares of worth about $67.77 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 27.90% during that period and on January 08, 2025 the price saw a gain […]
Analyst Expect Big Moves From Repligen Corp. (NASDAQ: RGEN)
BlackRock Fund Advisors recently announced the acquisition of new stake in Repligen Corp. (NASDAQ:RGEN). The institutional investor has increased its shareholding in the Healthcare company by 0.00% to 4.96 million shares with purchase of 97.0 shares. This fresh investment now brings its stake to 8.88% valued currently at $890.91 million. In addition, T. Rowe Price […]
